Search results

Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
PAP Therapies for HF: What Do the Trials Tell Us?
Author(s): Jan Pec , Michael Arzt Added: 3 months ago

Guidelines & Statements

Heart Failure
Liver Stiffness to Assess Central Venous Pressure in HF
Author(s): Nicolas Girerd Added: 9 months ago
ESC HF 25 - Outcomes from a study investigating liver stiffness measurement as a non-invasive method to assess central venous pressure showed immediate results at bedside obtained in >4 minutes, with the procedure easily performed by a trained nurse.Prof Nicolas Girerd (University Hospital of Nancy, Nancy, FR) discusses a pilot validation study investigating liver stiffness as a non-invasive… View more

Cardiovascular Renal Metabolic

Heart Failure
EASD 2025 Highlights: Updates on Icosapent Ethyl and Cardiometabolic Risk
Author(s): Rahul Aggarwal , Dirk Müller-Wieland Added: 5 months ago
Filmed onsite at EASD 2025, this on-demand series features key insights from Prof Dirk Müller-Wieland and Dr Rahul Aggarwal to interpret the latest data on eicosapentaenoic acid(EPA), including the latest sub-analysis of the REDUCE-IT trial, whichanalysed the effectiveness of icosapent ethyl (IPE) on CV risk by triglyceride-glucose (TyG) index - an indicator of insulin resistance and risk of type… View more

Heart Failure

Prevention & Chronic Conditions
Transvenous Phrenic Nerve Stimulation in Central Sleep Apnoea/Heart Failure
Author(s): Tarek Bekfani , Joseph D Abraham , William T Abraham Added: 6 months ago

Heart Failure
Home Sleep Apnoea Testing in Heart Failure
Author(s): Rebecca Steinberg , Andrew R Spector , Todd McVeigh , et al Added: 3 months ago

Heart Failure
Phrenic Nerve Stimulation for Central Sleep Apnoea
Author(s): Jonathan Na , Miguel Valderrábano , Paul Schurmann Added: 2 months ago

Electrophysiology & Arrhythmia

Heart Failure
Time in Target Ambulatory Blood Pressure Range Linked to Lower CV Risk
Added: 7 months ago Source:  Radcliffe Cardiology
A new meta-analysis suggests that the more time an individual's ambulatory blood pressure (ABP) is within the target range proposed by the 2024 European Society of Cardiology (ESC) guidelines, the lower their risk of mortality and cardiovascular events.¹ The findings also highlight that office blood pressure measurements frequently misclassify patients with regard to their actual blood pressure… View more

Demographic

Guidelines & Statements
Increasing VA-ECMO Flow Does Not Typically Raise Pulmonary Capillary Wedge Pressure in Cardiogenic Shock
Added: 6 months ago Source:  Radcliffe Cardiology
New research challenges the common assumption that high flow rates during venoarterial extracorporeal membrane oxygenation (VA-ECMO) increase pulmonary capillary wedge pressure (PCWP) and the risk of pulmonary oedema in patients with cardiogenic shock. The ECMO-Flow trial found that increasing VA-ECMO flow often has a neutral or even beneficial effect on PCWP, despite raising left ventricular… View more

Imaging & Diagnostics

Heart Failure
Added: 7 months ago Source:  Radcliffe CVRM
AUTHOR: Liam ONeillWhile elevated systolic blood pressure variability (SBPV) is a known risk factor for adverse health outcomes, new research published in the European Heart Journal suggests that the change in SBPV over time is also a critical prognostic indicator. The study found that an increase in visit-to-visit SBPV over a 10-year period was significantly associated with a higher risk of… View more

Cardiovascular Renal Metabolic

Heart Failure
Impact of Hypopnoea Classifications in Heart Failure
Author(s): Sébastien Baillieul , Renaud Tamisier , Jean-Louis Pépin Added: 3 months ago

Guidelines & Statements

Heart Failure